Dexpramipexole Development in Moderate-to-Severe Eosinophilic Asthma

Small-molecule immunological therapy entering Phase 3 clinical development

Scroll to discover

Dexpramipexole is also under investigation as a potential solution for those suffering with hypereosnophilic syndrome

Clinical Trials Are Underway

Read about our EXHALE Phase 2 trial in asthma

See the data

Want to Keep in Touch with Knopp?

Register for Updates.


Knopp Biosciences Biotechnology Saving & Improving Lives